Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Ipsen
Related studies linked through entity extraction aliases.
Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects
- Status
- COMPLETED
- Phase
- N/A
Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome
- Status
- COMPLETED
- Phase
- NA
A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours
- Status
- TERMINATED
- Phase
- N/A
Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours
- Status
- COMPLETED
- Phase
- N/A
Community-based Neuroendocrine Tumor (NET) Research Study
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
- Status
- COMPLETED
- Phase
- PHASE2
Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg
- Status
- TERMINATED
- Phase
- N/A
Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours
- Status
- TERMINATED
- Phase
- PHASE3
Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Insufficiency and Matched Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2
- Status
- TERMINATED
- Phase
- PHASE3
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg
- Status
- COMPLETED
- Phase
- PHASE2
Eziclen Drug Utilisation in Real Life Setting
- Status
- COMPLETED
- Phase
- N/A
Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs
- Status
- COMPLETED
- Phase
- N/A
Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone.
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2